PCV116 COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS
Abstract
Authors
M Schwenkglenks TD Szucs JE Brazier DJ Blackman P Cyr N Olchanski GW Stone